Rani Therapeutics
RANI
RANI
34 hedge funds and large institutions have $17.6M invested in Rani Therapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
42% less capital invested
Capital invested by funds: $30.4M → $17.6M (-$12.8M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Holders
34
Holding in Top 10
2
Calls
–
Puts
$5K
Top Buyers
| 1 | +$227K | |
| 2 | +$200K | |
| 3 | +$198K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$107K |
| 5 |
E
Ergoteles
New York
|
+$106K |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$822K | |
| 3 | -$181K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$179K |
| 5 |
Millennium Management
New York
|
-$94.4K |